Following an embryo transfer, providing thorough luteal phase support to the surrogate is vital to help sustain the uterine lining. This typically involves prescribed progesterone—administered via injections, oral tablets, or vaginal pessaries—and sometimes estrogen, depending on the specific protocol used. Medical follow-up begins with routine health checks to manage any mild physical symptoms. Around 10 to 14 days post-transfer, a serum beta-hCG blood test is scheduled to confirm pregnancy. If positive, hormonal support continues under close supervision, alongside early ultrasound scans to monitor gestational progress. Every surrogacy cycle requires individualized care, so following the specific medical regimen mapped out by the treating fertility team is essential.
For more, read Understanding Surrogate Meaning And The Process Of Surrogacy; consult Solo Clinic IVF; reference: Mayo Clinic.
After an embryo transfer, the surrogate’s body requires adequate hormonal backing to optimize the uterine environment for implantation. Luteal phase support primarily relies on micronized progesterone, often supplemented with estrogen, tailored to the surrogate's endometrial preparation protocol. Medical follow-up involves continuous monitoring for overall wellness and addressing any side effects promptly. A quantitative beta-hCG blood test is conducted approximately two weeks after the transfer to check for pregnancy. If the result is positive, the medication continues seamlessly into early pregnancy, supported by regular antenatal blood work and early viability scans. For specific medication schedules and follow-up protocols, personalized guidance from a certified fertility specialist is always recommended.
For more, read Understanding Surrogate Meaning And The Process Of Surrogacy; consult Apollo Fertility - Borivali East, Mumbai; reference: Mayo Clinic.
Luteal phase support is a cornerstone of post-transfer care for a surrogate, ensuring the endometrium remains receptive. We typically prescribe progesterone supplements, sometimes combined with estrogen, to mimic and support natural hormonal pathways. Close medical monitoring ensures the surrogate remains comfortable and well-supported throughout the two-week waiting period. We schedule a serum beta-hCG test about 12 to 14 days post-transfer to evaluate implantation. When pregnancy is established, this hormonal regimen is carefully tapered over several weeks while tracking early fetal development via ultrasound. Because every treatment protocol is unique, consulting the treating reproductive specialist is crucial for tailored management.
For more, read Understanding Surrogate Meaning And The Process Of Surrogacy; consult Dr. Parul Katiyar; reference: Mayo Clinic.
Caring for a surrogate post-embryo transfer involves both medical precision and compassionate monitoring. To support embryo implantation, we administer luteal phase medications, predominantly progesterone via intramuscular, oral, or vaginal routes, alongside estrogen if indicated. Medical follow-up includes tracking vital signs, assessing physical well-being, and providing continuous emotional support. The crucial next milestone is the beta-hCG pregnancy test, performed about two weeks after the procedure. If successful, ongoing hormonal therapy and scheduled early pregnancy ultrasounds are continued to ensure healthy fetal development. We always emphasize that individual protocols vary, and direct consultations with the supervising fertility consultant ensure the best path forward.
For more, read Understanding Surrogate Meaning And The Process Of Surrogacy; consult Atithi IVF Hospital; reference: Mayo Clinic.
In surrogacy cycles, meticulous luteal phase support is essential to maintain the receptive endometrium. The surrogate is prescribed bio-identical or micronized progesterone, often alongside estrogen support, based on the preparation cycle used. Clinical follow-up includes monitoring for any discomfort and ensuring medication compliance. Approximately 10 to 14 days following the embryo transfer, a quantitative serum beta-hCG test is conducted to determine pregnancy status. Upon a positive outcome, luteal medications are maintained through the first trimester under structured ultrasound surveillance to verify fetal viability. Because patient responses differ, individuals should always consult their fertility specialist for personalized clinical advice and care plans.
For more, read Understanding Surrogate Meaning And The Process Of Surrogacy; consult Oasis Fertility Centre - Bangalore; reference: Mayo Clinic.
Your insights help others make informed choices. Don’t hesitate to share!
Which option do you think is more emotionally fulfilling?
14 August 2026